{"product_id":"pt-141","title":"PT-141","description":"\u003cdiv style=\"max-width: 820px; margin: 0 auto; padding: 20px 0; font: 16px\/1.6 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,Helvetica,sans-serif; color: #122026;\"\u003e\n\n  \u003c!-- Title --\u003e\n  \u003ch2 style=\"margin: 0 0 6px; font-size: 24px; color: #154ba3;\"\u003e\n    \u003cstrong\u003ePT-141\u003c\/strong\u003e\n  \u003c\/h2\u003e\n\n  \u003c!-- Intro --\u003e\n  \u003cp style=\"margin: 8px 0 14px;\"\u003e\n    \u003cstrong\u003ePT-141\u003c\/strong\u003e, also known as bremelanotide, is a synthetic cyclic peptide studied for its interaction with melanocortin receptors, central nervous system signaling, receptor activation, and behavioral-response research pathways.\n  \u003c\/p\u003e\n\n  \u003cp style=\"margin: 8px 0 18px;\"\u003e\n    In research settings, PT-141 is commonly evaluated for its influence on melanocortin receptor activity, neural communication pathways, centrally mediated response models, receptor selectivity, and peptide structure-activity relationships.\n  \u003c\/p\u003e\n\n  \u003c!-- Key Research Areas --\u003e\n  \u003cdiv style=\"background: #f7faff; border: 1px solid rgba(21,75,163,0.16); border-left: 4px solid #154ba3; border-radius: 12px; padding: 16px; margin: 18px 0;\"\u003e\n    \u003ch3 style=\"margin: 0 0 10px; font-size: 18px; color: #154ba3;\"\u003e\n      Key Research Areas\n    \u003c\/h3\u003e\n\n    \u003cul style=\"margin: 0; padding-left: 20px;\"\u003e\n      \u003cli\u003e\n        \u003cstrong\u003eMelanocortin receptor activity\u003c\/strong\u003e and receptor-binding research\n      \u003c\/li\u003e\n      \u003cli\u003e\n        \u003cstrong\u003eCentral nervous system signaling\u003c\/strong\u003e and neural pathway analysis\n      \u003c\/li\u003e\n      \u003cli\u003e\n        \u003cstrong\u003eBehavioral-response models\u003c\/strong\u003e involving melanocortin signaling\n      \u003c\/li\u003e\n      \u003cli\u003e\n        \u003cstrong\u003eReceptor selectivity\u003c\/strong\u003e and melanocortin subtype interaction\n      \u003c\/li\u003e\n      \u003cli\u003e\n        \u003cstrong\u003ePeptide structure-activity relationships\u003c\/strong\u003e and cyclic peptide research\n      \u003c\/li\u003e\n    \u003c\/ul\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- Mechanism --\u003e\n  \u003ch3 style=\"margin: 20px 0 8px; font-size: 19px; color: #154ba3;\"\u003e\n    Mechanism of Interest\n  \u003c\/h3\u003e\n\n  \u003cp style=\"margin: 8px 0 14px;\"\u003e\n    PT-141 is studied as a melanocortin receptor agonist capable of interacting with multiple melanocortin receptor subtypes. Research models evaluate how this receptor activation may influence central neural signaling, behavioral responses, and communication between melanocortin-regulated pathways.\n  \u003c\/p\u003e\n\n  \u003cp style=\"margin: 8px 0 18px;\"\u003e\n    Unlike compounds that act primarily through peripheral vascular pathways, PT-141 is of research interest for its centrally mediated mechanism and its interaction with melanocortin signaling systems within the nervous system.\n  \u003c\/p\u003e\n\n  \u003c!-- Product Details --\u003e\n  \u003cdiv style=\"display: grid; gap: 10px; margin: 20px 0;\"\u003e\n    \u003cdiv style=\"border: 1px solid rgba(0,0,0,0.10); border-radius: 10px; padding: 12px;\"\u003e\n      \u003cstrong style=\"color: #154ba3;\"\u003eProduct Size:\u003c\/strong\u003e 10mg vial\n    \u003c\/div\u003e\n\n    \u003cdiv style=\"border: 1px solid rgba(0,0,0,0.10); border-radius: 10px; padding: 12px;\"\u003e\n      \u003cstrong style=\"color: #154ba3;\"\u003eCompound Class:\u003c\/strong\u003e Synthetic cyclic peptide \/ melanocortin receptor agonist\n    \u003c\/div\u003e\n\n    \u003cdiv style=\"border: 1px solid rgba(0,0,0,0.10); border-radius: 10px; padding: 12px;\"\u003e\n      \u003cstrong style=\"color: #154ba3;\"\u003eCAS Number:\u003c\/strong\u003e 189691-06-3\n    \u003c\/div\u003e\n\n    \u003cdiv style=\"border: 1px solid rgba(0,0,0,0.10); border-radius: 10px; padding: 12px;\"\u003e\n      \u003cstrong style=\"color: #154ba3;\"\u003eStorage:\u003c\/strong\u003e Store lyophilized material in a cool, dry environment protected from light. Refrigeration is recommended after reconstitution.\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003c!-- Why Researchers Study It --\u003e\n  \u003ch3 style=\"margin: 20px 0 8px; font-size: 19px; color: #154ba3;\"\u003e\n    Why Researchers Study PT-141\n  \u003c\/h3\u003e\n\n  \u003cp style=\"margin: 8px 0 14px;\"\u003e\n    PT-141 has gained interest in melanocortin and neurological research because its activity is associated with centrally mediated receptor pathways rather than relying exclusively on peripheral signaling mechanisms.\n  \u003c\/p\u003e\n\n  \u003cp style=\"margin: 8px 0 18px;\"\u003e\n    It is also examined in research involving receptor pharmacology, behavioral-response signaling, neural communication, melanocortin receptor subtype activity, and the biological properties of cyclic peptide analogs.\n  \u003c\/p\u003e\n\n  \u003c!-- Disclaimer --\u003e\n  \u003cdiv style=\"background: #154ba3; color: #ffffff; border-radius: 12px; padding: 16px; margin-top: 22px;\"\u003e\n    \u003cstrong style=\"color: #ffffff;\"\u003eResearch Use Only:\u003c\/strong\u003e\n    \u003cp style=\"margin: 8px 0 0;\"\u003e\n      This product is intended strictly for laboratory and research purposes. Not for human consumption, medical use, diagnostic use, or therapeutic use.\n    \u003c\/p\u003e\n  \u003c\/div\u003e\n\n\u003c\/div\u003e","brand":"Method Peptides","offers":[{"title":"10mg","offer_id":49747074482314,"sku":null,"price":50.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0611\/5531\/1754\/files\/pt-141-bremelanotide-10mg-research-peptide.jpg?v=1784230172","url":"https:\/\/methodpeptides.com\/products\/pt-141","provider":"Method Peptides","version":"1.0","type":"link"}